Special Edition: COVID-19 UpdateApril 20, 2020 | Oncology Allergy & Immunology Oncology Practice During the COVID-19 Pandemic This JAMA “Viewpoint” outlines the frameworks that should be used to inform decisions about how to modify cancer treatment based on patient and cancer-specific factors during these unprecedented COVID-19 times. Read full article Allergy & Immunology Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review Although no proven therapies exist, this JAMA article explores potential treatments for COVID-19 in repurposed drugs (chloroquine and hydroxychloroquine), lopinavir/ritonavir and other antiretrovirals, investigational drugs such as remdesivir, adjunctive therapies, and others. Read full article Allergy & Immunology 8-Year Study Shows Coronaviruses Have “Sharp Seasonality” According to a recent study published in Journal of Infectious Diseases, an analysis of four different coronaviruses (OC43, 229E, HKU1 and NL63) over an 8-year period demonstrated that they were detected in a limited timeframe, from December to April and May, with a peak during January and February. Read full article